Therapy Areas: Respiratory
Codetta Biosciences, North Carolina Central University Receive USD 2m Grant from the North Carolina Collaboratory
10 November 2022 - - The North Carolina Collaboratory has awarded North Carolina, US-based life sciences company Codetta Biosciences and North Carolina Central University a USD 2m research and development grant, aimed to dramatically impact COVID related research and future clinical care, the company said.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), also known as COVID-19, persists as a challenging world health crisis. Prevention, diagnosis, and treatment hinge on the ability to effectively detect SARS-CoV-2 and related health implications effectively and efficiently.

Therefore, Codetta and the NCCU Advanced Center for COVID-19 Related Disparities (ACCORD) will collaborate to make technologies for detection of COVID and assessment of COVID related health issues more accessible and efficient.

The Research Triangle Park, North Carolina based start-up is developing an integrated platform of reagents, hardware, and software designed to enable highly multiplexed, quantitative, simultaneous multi-omic analyses.

In collaboration with NCCU, Codetta will use the funding from the North Carolina Collaboratory to enable detection of a panel of respiratory infectious diseases, as well as severity of host response and potential impact of long-COVID.

The North Carolina Collaboratory awarded NCCU and Codetta the grant through their Business-Academic Partnership Program, aimed to address the public health and economic impacts of COVID-19 in North Carolina.

Codetta Biosciences' mission is to advance and expand life science research and diagnostic capabilities by providing an easy-to-use, streamlined multi-omic testing solution.

The company is developing and plans to commercialize a novel, fully integrated, multi-omic platform (instrument, software, consumables, with data analytics) that will set a new standard of multi-omic performance and simplicity, making this capability accessible to all researchers in commercial and diagnostic labs at a significantly lower price point than its current competitors.

With this platform, Codetta aims to advance the research and development of next-generation therapies, and ultimately improve patient care and quality of life.

North Carolina Central University prepares students to succeed in the global marketplace. Consistently ranked as a top Historically Black College or University, NCCU's flagship programs in the sciences, education, law, business, nursing and the arts prepare students for professions ranging from clinical research to information science.

The university's Strategic Plan 2019-2024, Charting a New Landscape for Student-Center Success, focuses on four areas: student access and success; innovation, research and entrepreneurship; collaboration and partnerships; and institutional sustainability.